These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 28860883)
21. Comparing Treatment Effect Measurements in Narcolepsy: The Sustained Attention to Response Task, Epworth Sleepiness Scale and Maintenance of Wakefulness Test. van der Heide A; van Schie MK; Lammers GJ; Dauvilliers Y; Arnulf I; Mayer G; Bassetti CL; Ding CL; Lehert P; van Dijk JG Sleep; 2015 Jul; 38(7):1051-8. PubMed ID: 25902810 [TBL] [Abstract][Full Text] [Related]
22. Factor structure and psychometric properties of a Persian translation of the Epworth Sleepiness Scale for Children and Adolescents. Imani V; Lin CY; Jalilolgadr S; Pakpour AH Health Promot Perspect; 2018; 8(3):200-207. PubMed ID: 30087843 [No Abstract] [Full Text] [Related]
23. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy. Sleep; 2003 Feb; 26(1):31-5. PubMed ID: 12627729 [TBL] [Abstract][Full Text] [Related]
24. The clinical characteristics of cataplectic attack in narcolepsy type 1. Huang B; Xu T; Wang Z; Chen K; Zhang J; Zhao Z; Zhuang J; Wu H Sleep Med; 2021 Jan; 77():261-269. PubMed ID: 31607435 [TBL] [Abstract][Full Text] [Related]
25. Clinical features of childhood narcolepsy. Can cataplexy be foretold? Nevsimalova S; Jara C; Prihodova I; Kemlink D; Sonka K; Skibova J Eur J Paediatr Neurol; 2011 Jul; 15(4):320-5. PubMed ID: 21345702 [TBL] [Abstract][Full Text] [Related]
26. The importance of social zeitgeber in paediatric type 1 narcolepsy: What we can learn from the COVID-19 restrictions adopted in Italy? Filardi M; D'Anselmo A; Mazzoni A; Moresco M; Pizza F; Plazzi G J Sleep Res; 2022 Feb; 31(1):e13423. PubMed ID: 34157781 [TBL] [Abstract][Full Text] [Related]
27. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review. Nittur N; Konofal E; Dauvilliers Y; Franco P; Leu-Semenescu S; Cock VC; Inocente CO; Bayard S; Scholtz S; Lecendreux M; Arnulf I Sleep Med; 2013 Jan; 14(1):30-6. PubMed ID: 23036267 [TBL] [Abstract][Full Text] [Related]
28. Antidepressants for the treatment of narcolepsy: A prospective study of 148 patients in northern China. Jin L; Shi L; Zhang Y; Chen BB; Wang XL; Liu YH J Clin Neurosci; 2019 May; 63():27-31. PubMed ID: 30837110 [TBL] [Abstract][Full Text] [Related]
29. Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy. Roth T; Dauvilliers Y; Guinta D; Alvarez-Horine S; Dynin E; Black J J Sleep Res; 2017 Aug; 26(4):407-414. PubMed ID: 27807903 [TBL] [Abstract][Full Text] [Related]
30. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients. Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923 [TBL] [Abstract][Full Text] [Related]
31. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate]. Poza-Aldea JJ Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563 [TBL] [Abstract][Full Text] [Related]
32. Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study. Luca G; Haba-Rubio J; Dauvilliers Y; Lammers GJ; Overeem S; Donjacour CE; Mayer G; Javidi S; Iranzo A; Santamaria J; Peraita-Adrados R; Hor H; Kutalik Z; Plazzi G; Poli F; Pizza F; Arnulf I; Lecendreux M; Bassetti C; Mathis J; Heinzer R; Jennum P; Knudsen S; Geisler P; Wierzbicka A; Feketeova E; Pfister C; Khatami R; Baumann C; Tafti M; J Sleep Res; 2013 Oct; 22(5):482-95. PubMed ID: 23496005 [TBL] [Abstract][Full Text] [Related]
33. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate. Huang YS; Guilleminault C Pediatr Neurol; 2009 Jul; 41(1):9-16. PubMed ID: 19520267 [TBL] [Abstract][Full Text] [Related]
35. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. U.S. Xyrem Multicenter Study Group Sleep Med; 2004 Mar; 5(2):119-23. PubMed ID: 15033130 [TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial. Szakacs Z; Dauvilliers Y; Mikhaylov V; Poverennova I; Krylov S; Jankovic S; Sonka K; Lehert P; Lecomte I; Lecomte JM; Schwartz JC; Lancet Neurol; 2017 Mar; 16(3):200-207. PubMed ID: 28129985 [TBL] [Abstract][Full Text] [Related]
37. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Heier MS; Gautvik KM; Wannag E; Bronder KH; Midtlyng E; Kamaleri Y; Storsaeter J Sleep Med; 2013 Sep; 14(9):867-71. PubMed ID: 23773727 [TBL] [Abstract][Full Text] [Related]